Insider · CIK 0001568734
John Thomas Burns
Files at SLS (SELLAS Life Sciences Group, Inc.). First filing -, latest -.
In brief
John Thomas Burns files SEC Form 4 as CFO at SLS (SELLAS Life Sciences Group, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John Thomas Burns has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | SLS SELLAS Life Sciences Group, Inc. | AGrant or award Common Stock | +300,000 | $0.00 | $0 | 554,327 | Jan 9, 2026 |
| Dec 3, 2025 | SLS SELLAS Life Sciences Group, Inc. | JOther Common Stock | -58,592 | $1.50 | $88k | 254,327 | Dec 5, 2025 |
| Jan 10, 2025 | SLS SELLAS Life Sciences Group, Inc. | AGrant or award Common Stock | +113,000 | $0.00 | $0 | 217,762 | Jan 14, 2025 |
| Jan 10, 2025 | SLS SELLAS Life Sciences Group, Inc. | AGrant or award Common Stock | +81,300 | $0.00 | $0 | 299,062 | Jan 14, 2025 |
| Jan 10, 2025 | SLS SELLAS Life Sciences Group, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +169,500 | $0.00 | $0 | 169,500 | Jan 14, 2025 |
| Dec 4, 2024 | SLS SELLAS Life Sciences Group, Inc. | JOther Common Stock | -7,165 | $1.13 | $8,096 | 104,762 | Dec 5, 2024 |
Questions about John Thomas Burns
Answered from the filings on this page, as of the latest one.
Is John Thomas Burns buying or selling?
John Thomas Burns has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John Thomas Burns's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Thomas Burns has 0.
Where does John Thomas Burns file Form 4?
John Thomas Burns has filed Form 4 at SLS (SELLAS Life Sciences Group, Inc.) as CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.